KTTA Pasithea Therapeutics Corp.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1841330 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-84.0%
TTM EPS YoY68.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-88.8%
ROA-82.6%
ROIC (approx.)-414.6%
Asset turnover—
Leverage & solvency
Liabilities / assets5.9%
Debt / equity0.00x
Current ratio15.67x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.78x
Accruals ratio-18.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $7.98M | $7.20M |
| SG&A expense | $12.88M | $7.05M |
| Operating income | -$20.86M | -$14.25M |
| Pretax income | -$20.43M | -$13.90M |
| Net income | -$20.43M | -$13.90M |
| EBITDA | -$20.82M | -$14.23M |
| EPS (basic) | -2.91 | -12.69 |
| EPS (diluted) | -2.91 | -12.69 |
| Weighted avg. shares (diluted) | 7.03M | 1.10M |
| Balance sheet | ||
| Cash & equivalents | $55.16M | $6.92M |
| Current assets | $56.46M | $7.37M |
| PP&E, net | — | $122,343 |
| Goodwill | — | $1.26M |
| Intangibles | $2.90M | $7.31M |
| Total assets | $60.24M | $16.06M |
| Current liabilities | $4.97M | $1.12M |
| Total liabilities | $5.02M | $1.28M |
| Shareholders' equity | $55.22M | $14.78M |
| Shares outstanding | 23.09M | 1.39M |
| Cash flow statement | ||
| Operating cash flow | -$15.21M | -$13.92M |
| Investing cash flow | $11,000 | — |
| Financing cash flow | $63.52M | $4.52M |
| Depreciation & amortization | $32,421 | $18,865 |
| Stock-based compensation | $297,467 | $773,693 |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.